← Back
$ARQT All transactions

Arcutis Biotherapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$9K

Shares

504

Price

$18

Filed

Sep 10

Insider

Name

Watanabe Todd

Title

See Remarks

CIK

0001801061

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-09

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

891,440

Footnotes

The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 14, 2024, by the Reporting Person, with a plan end date of September 30, 2025. | The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $17.50 to $17.59, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $17.50 to $17.54, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. | The securities are held of record by The John Franklin Watanabe Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes. | The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes. | The securities are held of record by Watanabe Ventures, LLC, of which the Reporting Person is the Chief Operating Officer. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes. | The securities are held of record by The Watanabe 2016 Irrevocable Trust, of which the Reporting Person's children are beneficiaries. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Filing Info

Accession No.

0001787306-25-000136

Form Type

4

Issuer CIK

0001787306

Watanabe Todd's History

Date Ticker Type Value
2026-03-02 ARQT $913K
2026-03-02 ARQT $28K
2026-02-27 ARQT A $0
2026-02-27 ARQT A $0
2026-02-02 ARQT $506K
2025-11-24 ARQT $1.5M
2025-11-21 ARQT $32K
2025-11-03 ARQT $284K
2025-11-03 ARQT $2K
2025-10-28 ARQT $1.0M

Other Insiders at ARQT (90d)

Insider Bought Sold Last
Leonard Keith R $997K 2026-03-02
Burnett Patrick
See Remarks
$505K 2026-03-02
Matsuda Masaru
See Remarks
$1.3M 2026-03-02
Welgus Howard G. $746K 2026-04-01
Watanabe Todd
See Remarks
$1.4M 2026-03-02
Edwards Larry Todd
See Remarks
$145K 2026-03-02
Vairavan Latha
SVP Chief Financial Officer
$106K 2026-03-02